Filtered By:
Condition: SARS
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 1917 results found since Jan 2013.
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach
Publication date: Available online 18 June 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Matthew Greenhawt, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David Kahn, Cem Akin, Waleed Alqurashi, Peter Arkwright, James L. Baldwin, Moshe Ben-Shoshan, Jonathan Bernstein, Theresa Bingeman, Katerina Blumchen, Aideen Byrne, Antonio Bognanni, Dianne Campbell, Ronna Campbell, Zain Chagla, Edmond S. Chan, Jeffrey Chan
Source: The Journal of Allergy and Clinical Immunology: In Practice - June 18, 2021 Category: Allergy & Immunology Source Type: research
Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection
Conclusion: This study revealed that pediatric patients diagnosed with asthma were in a mild clinic. According to these findings, asthma may not affect the course of the COVID-19 in children.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - June 24, 2021 Category: Allergy & Immunology Source Type: research
Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic
Ann Allergy Asthma Immunol. 2021 Jul;127(1):3-4. doi: 10.1016/j.anai.2021.03.017.NO ABSTRACTPMID:34154787 | PMC:PMC8213382 | DOI:10.1016/j.anai.2021.03.017
Source: Annals of Allergy, Asthma and Immunology - June 22, 2021 Category: Allergy & Immunology Authors: Ryan Eid Larry Borish Source Type: research
Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19
Publication date: Available online 25 June 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Rohan Ameratunga, Hilary Longhurst, Richard Steele, Klaus Lehnert, Euphemia Leung, Anna E.S. Brooks, See-Tarn Woon
Source: The Journal of Allergy and Clinical Immunology: In Practice - June 27, 2021 Category: Allergy & Immunology Source Type: research
Asthma-related outcomes during the SARS-CoV2 pandemic: A single-center observational study
Publication date: Available online 16 June 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Amani Al-Hazaymeh, James Patrie, Jason C. Adams, Larry Borish, Emily C. McGowan
Source: The Journal of Allergy and Clinical Immunology: In Practice - June 28, 2021 Category: Allergy & Immunology Source Type: research
The impact of inhaled corticosteroid on SARS-CoV2 infection
Publication date: July 2021Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 9, Issue 7Author(s): Chih-Cheng Lai
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 7, 2021 Category: Allergy & Immunology Source Type: research
Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa
CONCLUSION: Inflammatory endotype affects ACE2 expression in the nasal mucosa and influences susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In particular, type 2 inflammation could downregulate ACE2 expression in the nasal mucosa and reduces susceptibility to SARS-CoV-2 in patients with CRSwNP. Although in vivo experiments are required, administration of SCFAs to the nasal cavity might be worthy of consideration as a preventative or therapeutic strategy for the early-stage COVID-19.PMID:34232770 | DOI:10.1177/19458924211027798
Source: American Journal of Rhinology and Allergy - July 7, 2021 Category: ENT & OMF Authors: Tetsuji Takabayashi Kanako Yoshida Yoshimasa Imoto Robert P Schleimer Shigeharu Fujieda Source Type: research
Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia
Publication date: Available online 12 July 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Rachel H.F. Margolis, Shilpa J. Patel, William J. Sheehan, Joelle N. Simpson, Nikita Kachroo, Burak Bahar, Stephen J. Teach
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 13, 2021 Category: Allergy & Immunology Source Type: research
DETECTION OF NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS FOLLOWING IMMUNIZATION WITH mRNA VACCINES
Ann Allergy Asthma Immunol. 2021 Aug 2:S1081-1206(21)00523-8. doi: 10.1016/j.anai.2021.07.026. Online ahead of print.NO ABSTRACTPMID:34352358 | PMC:PMC8327608 | DOI:10.1016/j.anai.2021.07.026
Source: Annals of Allergy, Asthma and Immunology - August 5, 2021 Category: Allergy & Immunology Authors: Ciro Romano Sergio Esposito Giovanna Donnarumma Aldo Marrone Source Type: research
Montelukast and Coronavirus Disease 2019: A Scoping Review
Iran J Allergy Asthma Immunol. 2021 Aug 7;20(4):384-393.ABSTRACTCoronavirus disease 2019 (COVID-19) is an emerging worldwide issue, that has affected a large number of people around the world. So far, many studies have aimed to develop a therapeutic approach against COVID-19. Montelukast (MK) is a safe asthma controller drug, which is considered as a potential antiviral drug for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This review has a systematic approach to investigate the reports on the use of MK as a part of treatment or a prophylactic agent in COVID-19. The search was conducted in PubMed, Web of S...
Source: Iranian Journal of Allergy, Asthma and Immunology - August 22, 2021 Category: Allergy & Immunology Authors: Niusha Sharifinejad Samin Sharafian Sana Salekmoghadam Marzieh Tavakol Mostafa Qorbani Source Type: research
